Caring for those with treatment-resistant depression

Genoa Healthcare® can partner with you to improve outcomes for your patients living with TRD. Connect with us to get started today.

One in three adults with major depressive disorder are diagnosed with treatment-resistant depression (TRD), affecting around 1.1% of the general U.S. population. But what exactly is treatment-resistant depression? 

The term treatment-resistant depression most often refers to major depressive episodes – occurrences when symptoms of depression occur most of the day, nearly every day₁ – that do not respond satisfactorily to at least two trials of optimally dosed antidepressant monotherapy. However, this definition has not yet been standardized₂.

Read on to learn more about TRD and the treatment options that exist for the people you serve.

Want to learn more about TRD?

Watch Genoa Healthcare’s most recent webinar which features senior clinical pharmacist Kim Cordova, PharmD, and pharmacy operations manager Alicia Garcia Afa, PharmD, as they discuss advances in pharmacy care for individuals living with TRD.

Watch the recording below to learn more:

A pharmacist on your team

Studies show that pharmacy-led support helps break down barriers to effective TRD treatments. Genoa pharmacy teams partner with organizations like yours to provide high-touch pharmacy care to the people you serve, meeting your consumers where they are and helping them manage complex care plans.

Interested in learning more about TRD-specific treatment options? Click the flags below to learn more.

4 things to know about Spravato® Currently available + emerging therapy options for TRD

[1] https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007

[2] https://www.uptodate.com/contents/unipolar-treatment-resistant-depression-in-adults-epidemiology-risk-factors-assessment-and-prognosis?sectionName=Treatment-resistant%20depression&topicRef=14685&anchor=H6075260&source=see_link#H6075260

[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293424/